Please use this identifier to cite or link to this item:
|Title:||Runx3 Inactivation Is a Crucial Early Event in the Development of Lung Adenocarcinoma||Authors:||Lee, Y.-S.
|Issue Date:||11-Nov-2013||Citation:||Lee, Y.-S., Lee, J.-W., Jang, J.-W., Chi, X.-Z., Kim, J.-H., Li, Y.-H., Kim, M.-K., Kim, D.-M., Choi, B.-S., Kim, E.-G., Chung, J.-H., Lee, O.-J., Lee, Y.-M., Suh, J.-W., Chuang, L., Ito, Y., Bae, S.-C. (2013-11-11). Runx3 Inactivation Is a Crucial Early Event in the Development of Lung Adenocarcinoma. Cancer Cell 24 (5) : 603-616. ScholarBank@NUS Repository. https://doi.org/10.1016/j.ccr.2013.10.003||Abstract:||Targeted inactivation of Runx3 in mouse lung induced mucinous and nonmucinous adenomas and markedly shortened latency of adenocarcinoma formation induced by oncogenic K-Ras. RUNX3 was frequently inactivated in K-RAS mutated human lung adenocarcinomas. A functional genetic screen of a fly mutant library and molecular analysis in cultured cell lines revealed that Runx3 forms a complex with BRD2 in a K-Ras-dependent manner in the early phase of the cell cycle; this complex induces expression of p14ARF/p19Arf and p21WAF/CIP. When K-Ras was constitutively activated, the Runx3-BRD2 complex was stably maintained and expression of both p14ARF and p21WAF/CIP was prolonged. These results provide a missing link between oncogenic K-Ras and the p14ARF-p53 pathway, and may explain how cells defend against oncogenic K-Ras. © 2013 Elsevier Inc.||Source Title:||Cancer Cell||URI:||http://scholarbank.nus.edu.sg/handle/10635/115922||ISSN:||15356108||DOI:||10.1016/j.ccr.2013.10.003|
|Appears in Collections:||Staff Publications|
Show full item record
Files in This Item:
There are no files associated with this item.
checked on Nov 14, 2019
WEB OF SCIENCETM
checked on Nov 6, 2019
checked on Nov 8, 2019
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.